Turna Ray on Muck Rack

Turna Ray

Verified
New York
As seen in: 360Dx, GenomeWeb, Precision Oncology News, The World from PRX, Crain's Chicago Business, Science Friday, Modern Healthcare, Precision Medicine Online
Journalist: Personalized medicine, genomics, cancer @GenomeWeb genomeweb.com Managing editor: Precision Medicine Online precisionmedicineonline.com
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Turna

Contact Turna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ASCO Won't Recommend Galleri as NHS Trial Data Reignites Debate Over MCED Evidence Standards

|
By Kelsy Ketchum , Turna Ray 
| GenomeWeb
CHICAGO – The American Society of Clinical Oncology will not recommend Grail's Galleri test for detecting cancers early after seeing data from a large, prospective randomized-controlled trial.
Open in Who Shared View Duplicates (2) Issue with article?

ASCO Won't Recommend Galleri as NHS Trial Data Reignites Debate Over MCED Evidence Standards

|
By Kelsy Ketchum , Turna Ray 
| Precision Medicine Online
CHICAGO – The American Society of Clinical Oncology will not recommend Grail's Galleri test for detecting cancers early after seeing data from a large, prospective randomized-controlled trial.
Open in Who Shared Issue with article?

FDA Advisory Panel Unconvinced on ctDNA-based Breast Cancer Treatment Switching

|
By Turna Ray 
| GenomeWeb
NEW YORK – The majority of experts on a US Food and Drug Administration advisory panel on Thursday remained unconvinced that there's sufficient evidence to support giving certain advanced breast cancer patients AstraZeneca's camizestrant if they appear to be developing resistance to first-line therapy based on the presence of ESR1 mutations in their blood, but before they show signs of disease progression on scans.
Open in Who Shared Issue with article?
See all 438 articles

Actions

Share this page

Get in touch with Turna

Contact Turna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified